Colgate-Palmolive (NYSE:CL) Expected to Announce Quarterly Sales of $3.79 Billion

Wall Street analysts expect that Colgate-Palmolive (NYSE:CL) will post sales of $3.79 billion for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Colgate-Palmolive’s earnings, with the highest sales estimate coming in at $3.87 billion and the lowest estimate coming in at $3.70 billion. Colgate-Palmolive posted sales of $3.87 billion during the same quarter last year, which would indicate a negative year-over-year growth rate of 2.1%. The firm is expected to report its next earnings report on Friday, July 24th.

On average, analysts expect that Colgate-Palmolive will report full year sales of $15.76 billion for the current year, with estimates ranging from $15.40 billion to $16.05 billion. For the next fiscal year, analysts forecast that the company will report sales of $16.09 billion, with estimates ranging from $15.61 billion to $16.26 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.75 EPS for the quarter, topping the consensus estimate of $0.73 by $0.02. Colgate-Palmolive had a net margin of 15.86% and a return on equity of 942.99%. The firm had revenue of $4.10 billion for the quarter, compared to analysts’ expectations of $4.07 billion. During the same period in the previous year, the firm posted $0.67 EPS. The company’s revenue for the quarter was up 5.5% on a year-over-year basis.

Several research firms have recently weighed in on CL. Stifel Nicolaus boosted their price objective on shares of Colgate-Palmolive from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. SunTrust Banks boosted their price objective on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, May 15th. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $72.00 to $78.00 and gave the stock an “overweight” rating in a research note on Monday, April 27th. Atlantic Securities upgraded shares of Colgate-Palmolive from a “neutral” rating to an “overweight” rating in a research note on Monday, February 3rd. Finally, Royal Bank of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and boosted their price objective for the stock from $69.00 to $91.00 in a research note on Monday, February 3rd. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $75.60.

In other news, Chairman Ian M. Cook sold 28,122 shares of the company’s stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $75.27, for a total transaction of $2,116,742.94. Following the completion of the sale, the chairman now owns 899,015 shares of the company’s stock, valued at approximately $67,668,859.05. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Daniel B. Marsili sold 4,030 shares of the company’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $75.45, for a total transaction of $304,063.50. Following the sale, the insider now directly owns 51,788 shares of the company’s stock, valued at approximately $3,907,404.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 80,132 shares of company stock valued at $5,774,879. 0.78% of the stock is currently owned by insiders.

A number of large investors have recently modified their holdings of CL. Wealth Quarterback LLC acquired a new stake in Colgate-Palmolive in the fourth quarter worth $19,416,210,000. Capital World Investors bought a new position in shares of Colgate-Palmolive in the first quarter valued at $829,740,000. Norges Bank bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $583,948,000. Massachusetts Financial Services Co. MA lifted its stake in shares of Colgate-Palmolive by 5.0% in the first quarter. Massachusetts Financial Services Co. MA now owns 35,125,475 shares of the company’s stock valued at $2,330,928,000 after buying an additional 1,686,475 shares in the last quarter. Finally, Amundi Pioneer Asset Management Inc. lifted its stake in shares of Colgate-Palmolive by 129.6% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 2,517,419 shares of the company’s stock valued at $173,291,000 after buying an additional 1,420,929 shares in the last quarter. 74.79% of the stock is owned by institutional investors and hedge funds.

NYSE:CL traded up $0.49 on Wednesday, hitting $70.75. 3,427,409 shares of the company’s stock were exchanged, compared to its average volume of 4,410,119. The firm has a 50-day moving average price of $69.93 and a 200-day moving average price of $69.58. The company has a debt-to-equity ratio of 21.51, a current ratio of 0.96 and a quick ratio of 0.66. Colgate-Palmolive has a 52 week low of $58.49 and a 52 week high of $77.41. The company has a market cap of $60.18 billion, a P/E ratio of 24.15, a price-to-earnings-growth ratio of 4.62 and a beta of 0.60.

The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were issued a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date was Friday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.43. Colgate-Palmolive’s dividend payout ratio is 62.19%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: How to Invest in an Index Fund

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.